93 related articles for article (PubMed ID: 7700697)
1. [Evaluation of various experimental dyslipoproteinemia models in the study of hypolipidemic agents].
Ryzhenkov VE; Chistiakova AM; Frolova IuV; Lozovskiĭ VT; Kameneva IIu; Vasil'eva LE
Patol Fiziol Eksp Ter; 1994; (4):33-6. PubMed ID: 7700697
[TBL] [Abstract][Full Text] [Related]
2. [The hypolipidemic action of water-soluble enterosorbents of cholesterol and bile acids in an experiment].
Chistiakova AM; Frolova IuV; Triufanov VF; Vasil'eva LE; Lozovskiĭ VT; Ryzhenkov VE
Eksp Klin Farmakol; 1992; 55(5):41-4. PubMed ID: 1305451
[TBL] [Abstract][Full Text] [Related]
3. [The effect of the mineral composition of the diet on cholesterol metabolic indices and the experimental correction of propranolol-induced atherogenic dyslipoproteinemia].
Shtrygol' SIu
Eksp Klin Farmakol; 1995; 58(1):29-31. PubMed ID: 7787690
[TBL] [Abstract][Full Text] [Related]
4. [The hypolipidemic activity of natural substances].
Okunevich IV; Kliueva NN; Solov'eva MA; Triufanov VF; Ryzhenkov VE
Eksp Klin Farmakol; 1992; 55(5):44-7. PubMed ID: 1305452
[TBL] [Abstract][Full Text] [Related]
5. [Hypolipidemic activity of a water extract from roots carline thistle].
Iudina TP; Tsybul'ko EI; Cherevach EI; Babin IuV; Kropotov AV; Plaksen NV; Khil'chenko NS
Vopr Pitan; 2005; 74(4):31-2. PubMed ID: 16265913
[TBL] [Abstract][Full Text] [Related]
6. [Changes in the blood serum lipids and lipoproteins of rats in ovariectomy and to the administration of the methyl ester of 6-hydroxy-D-homo-8-isoestrone].
Kameneva IIu; Shavva AG; Lozovskiĭ VG; Ryzhenkov VE
Biull Eksp Biol Med; 1992 Jul; 114(8):148-50. PubMed ID: 1467476
[TBL] [Abstract][Full Text] [Related]
7. [Lipanor treatment of atherogenic hyperlipoproteinemia].
Susekov AV; Tvorogova MG; Arabidze GG; Kukharchuk VV
Ter Arkh; 1998; 70(9):57-61. PubMed ID: 9821228
[TBL] [Abstract][Full Text] [Related]
8. [The hypolipidemic and antiatherosclerotic action of absorbable and nonabsorbable substances in the intestines].
Ryzhenkov VE; Chistiakova AM; Okunevich IV
Patol Fiziol Eksp Ter; 1989; (5):16-9. PubMed ID: 2616207
[TBL] [Abstract][Full Text] [Related]
9. [Role of the patho-autokinetic element in the pathogenesis of disturbances of myocardial lipid composition induced by experimental atherogenic dyslipoproteinemia].
Kalinkin MN
Patol Fiziol Eksp Ter; 1991; (5):14-7. PubMed ID: 1806882
[TBL] [Abstract][Full Text] [Related]
10. [Pharmacological correction of lipid metabolism disturbances using new amide derivatives of taurine].
Okunevich IV; Gavrovskaia LK; Sapronov NS
Eksp Klin Farmakol; 2007; 70(2):48-50. PubMed ID: 17523452
[TBL] [Abstract][Full Text] [Related]
11. A quarter century of drug treatment of dyslipoproteinemia, with a focus on the new HMG-CoA reductase inhibitor fluvastatin.
Levy RI; Troendle AJ; Fattu JM
Circulation; 1993 Apr; 87(4 Suppl):III45-53. PubMed ID: 8462180
[TBL] [Abstract][Full Text] [Related]
12. [Dyslipoproteinemia in elderly patients].
Bláha V; Solichová D; Zadák Z
Vnitr Lek; 2000 Sep; 46(9):551-4. PubMed ID: 11344651
[TBL] [Abstract][Full Text] [Related]
13. Atheroprotective effect of exogenous heparin-derivative treatment on the aortic disturbances and lipoprotein oxidation in hypercholesterolemic diet fed rats.
Deepa PR; Varalakshmi P
Clin Chim Acta; 2005 May; 355(1-2):119-30. PubMed ID: 15820486
[TBL] [Abstract][Full Text] [Related]
14. [A specialized product with antioxidant action in the treatment of lipid disorders in experimental hyperlipoproteinemia].
Ivanova IL; Ian'kova VI; Knyshova VV; Kozlovskaia EP
Vopr Pitan; 2000; 69(1-2):13-5. PubMed ID: 10942997
[TBL] [Abstract][Full Text] [Related]
15. [Hypolipidemic action of phospholipid compounds in experimental animals].
Okunevich IV; Ryzhenkov VE; Ulesov AV; Makarevich IF; Mokrouz MV; Davigora IV
Vopr Pitan; 1994; (3):19-21. PubMed ID: 7975417
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of dyslipoproteinemia by systemic enzyme therapy in experimental glomerulonephritis].
Mukhin IV
Patol Fiziol Eksp Ter; 2002; (4):27-8. PubMed ID: 12638428
[TBL] [Abstract][Full Text] [Related]
17. Curcumin attenuates diet-induced hypercholesterolemia in rats.
Arafa HM
Med Sci Monit; 2005 Jul; 11(7):BR228-234. PubMed ID: 15990684
[TBL] [Abstract][Full Text] [Related]
18. [A study of the effect of some hypolipidemic substances].
Synková J
Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1978; 21(4):401-25. PubMed ID: 316922
[No Abstract] [Full Text] [Related]
19. Effect of L-carnitine on plasma lipoprotein fatty acids pattern in patients with primary hyperlipoproteinemia.
Stefanutti C; Vivenzio A; Lucani G; Di Giacomo S; Lucani E
Clin Ter; 1998; 149(2):115-9. PubMed ID: 9780475
[TBL] [Abstract][Full Text] [Related]
20. Lipid lowering activity of ethanolic extract of leaves of Aegle marmelos (Linn.) in hyperlipidaemic models of Wistar albino rats.
Vijaya C; Ramanathan M; Suresh B
Indian J Exp Biol; 2009 Mar; 47(3):182-5. PubMed ID: 19405383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
